| 指标 | 2027财年第一季度 | 同比比较 / 背景 |
|---|---|---|
| 营收 | 4.03亿美元 | 增长5%;创第一季度历史新高 |
| 产品营收 | 2.90亿美元 | 增长5% |
| 服务营收 | 1.14亿美元 | 增长4% |
| 调整后摊薄每股收益 | 1.66美元 | 增长17%;创第一季度历史新高 |
| 毛利率 | 30.7% | 低于32.0% |
| 调整后营业利润率 | 9.5% | 低于10.3% |
| 经营活动现金流 | 3700万美元 | 高于1700万美元 |
| 自由现金流 | 约3000万美元 | 约为GAAP净利润的120% |
| 订单出货比 | 1.4 | 支撑创纪录的在手订单增长 |
| 在手订单 | 21亿美元 | 高于截至6月30日的约19亿美元 |
| 摊薄股数 | 1630万股 | 较1750万股下降7% |
销售、一般及管理费用(SG&A)为6900万美元,占营收的17.0%,而上年同期为17.4%。研发费用为1940万美元,占营收的4.8%。不含重组及其他成本的总营业费用占销售额的比例从22.7%降至21.8%。
利息及其他费用从740万美元降至330万美元,反映出借贷成本降低和投资收益增加。管理层指出,利息费用减少和股数减少对每股收益增长做出了显著贡献。
截至本季度末,OSI Systems拥有2.36亿美元的现金和现金等价物、6600万美元的短期投资以及约10亿美元的债务。其中超过90%的债务为固定利率债务。该公司以接近204美元的均价回购了约30.6万股股票,耗资约6200万美元。
尽管受到中东冲突和墨西哥项目过渡的影响,安防业务营收仍增长4%至2.64亿美元。墨西哥项目的过渡使第一季度营收减少了约800万美元,这与管理层的财年展望一致。
该部门在本季度末录得创纪录的在手订单。OSI Systems获得了美国海关与边境保护局(CBP)的两份五年期不确定交付时间/不确定交付数量(IDIQ)合同:一份上限约为2亿美元,用于可移动式快速扫描乘用车检查系统;另一份上限约为8500万美元,用于车载移动X光检查系统。初始交付订单总计约2100万美元。只有确定订单(而非合同上限金额)才会被计入在手订单。
射频(RF)业务继续推进一项最高金额不超过约2.35亿美元的国土防空超视距雷达合同。OSI Systems还宣布获得了约9000万美元的追加射频订单。管理层表示,这份2.35亿美元的合同在第一季度贡献了营收,并应在2027财年期间继续贡献,而较新的订单预计将为2027财年及后续年份提供支撑。
安防业务的调整后营业利润率为12.6%。管理层预计,随着时间的推移,较高利润率的服务收入在业务结构中的占比将进一步扩大。该公司还正准备担任2028年洛杉矶奥运会和残奥会(LA28)的官方物理安检与安防技术硬件/软件解决方案提供商。
包含公司内部销售在内,光电子业务营收增长9%,达到创第一季度历史新高的1.20亿美元。来自外部客户的营收增长了16%。
营收增长的同时伴随着营业利润率的扩大,调整后营业利润率达到12.1%。电子制造服务(EMS)、柔性电路板和光电子产品线的订单表现强劲,该部门在该季度末录得创纪录的季度末在手订单。
医疗保健业务营收下降14%,主要是因为医院继续对资本支出持谨慎态度,从而减少了病人监护设备的销售。该部门录得负1.8%的调整后营业利润率。
管理层正专注于支持已安装设备群,提高运营效率并完成其下一代监护平台。该公司预计医疗保健业务将在未来几个季度恢复增长。
OSI Systems重申2027财年营收指引为18.75亿至19.30亿美元。调整后每股收益指引上调至11.28-11.64美元,代表预期同比增长9%至12.5%。管理层将这一上调主要归因于第一季度股票回购的影响,而非经营展望的变化。
管理层预计,由于中东地区高基数比较难度以及预计约1100万美元的墨西哥项目逆风,2027财年第二季度营收将同比略有下降。随着在手订单转化和安防服务业务加速,预计下半年的营收增长最为强劲。
该公司预计2027财年服务收入将实现强劲的双位数增长,从第二季度开始并在下半年进一步走强。驱动因素包括出保产品增加、航空服务、SaaS产品以及射频业务活力的提升。
随着营收增长以及较高利润率的服务业务在结构中占比提升,预计毛利率和营业利润率将在2027财年余下时间内有所改善。管理层还继续预计全年自由现金流将超过净利润。
管理层表示,创纪录的在手订单为2027财年营收提供了潜在的上行空间,并提高了2028财年及以后的能见度,但地缘政治不确定性促使公司维持现有的营收范围。
在此前从第四财季推迟的约5000万美元中东收入中,约800万美元已在第一财季确认。管理层继续预计剩余大部分金额将在2027财年下半年及2028财年确认。
服务收入增长预计将从第二季度开始显著加速。管理层将出保产品、航空服务、SaaS收入和射频业务列为能见度相对较高的领域。
在射频产能方面,管理层表示两个新设施以及增加第二班次的选择应能支持当前的储备项目。如果需要,还可以增加更多设施。该公司还打算继续投资于射频研发。
资本配置的优先顺序仍为有机投资、战略收购、择机股票回购和保持坚实的资产负债表。管理层表示,收购需要能够提高市场渗透率或增加补充能力。
Thank you. Good day and thank you for standing by. Welcome to the OSI Systems, Inc. First Quarter Fiscal 2027 Earnings Conference Call.
[Operator Instructions]
I would now like to hand the conference over to your speaker today, Alan Edrick, Chief Financial Officer. Sir, please go ahead. Thank you.
Well, thank you. Good afternoon and thank you for joining us. I'm Alan Edrick, Executive Vice President and CFO of OSI Systems, and I'm here today with Ajay Mehra, OSI's President and CEO. Welcome to the OSI Systems Fiscal '27 First Quarter Conference Call. We are pleased to join you as we review our financial and our operational results. Today's discussion will include forward-looking statements, and the company wishes to take advantage of the safe harbor provision of the Private Securities Litigation Reform Act of 1995 with respect to such statements. All forward-looking statements made in this call are based on currently available information, and the company undertakes no obligation to update any forward-looking statement based on subsequent events or new information or otherwise. We will also reference both GAAP and non-GAAP financial measures.
Applicable reconciliations are available in today's earnings release. On our August call, we told you three things about fiscal '27: that we had built our guidance factoring in the situation in the Middle East, that we expected growth to be strongest in the second half, and that we expected free cash flow to exceed net income. These three factors will frame our discussion this quarter. First quarter revenues were $403 million, representing a Q1 record up 5% year-over-year. And adjusted earnings per diluted share grew to a first quarter record of $1.66, up 17% year-over-year. Operating cash flow was $3.7 million, more than double the same prior year quarter, and free cash flow, which is operating cash flow less capital expenditures, was approximately $30 million, about 120% of GAAP net income. Q1 bookings were strong. Our book-to-bill ratio was 1.4, and our backlog increased to a record $2.1 billion from approximately $1.9 billion at June 30th. I also want to be direct about certain reported figures for the first fiscal quarter.
A meaningful part of our EPS growth this quarter came from below the operating line, with lower net interest expense and a lower share count, and I'll quantify those for you later in this call. Margins were impacted by a revenue decline in the Healthcare division and the mix of revenues and Security, both of which Ajay and I will address. But before diving more deeply into our financial results and discussing our outlook for fiscal '27, I'm going to turn the call over to Ajay.
Thank you, Alan, and thanks to all of you for joining us today. As Alan mentioned, we achieved record fiscal first quarter revenues and earnings per share. Our activity was strong, resulting in a book-to-bill ratio of 1.4, which increased our backlog to a record $2.1 billion. The first quarter played out largely as we outlined on our last call. Bookings were strong, backlog grew to a new all-time high, and we remain on track for a stronger second half of fiscal 2027. Now, let me turn to our three divisions, starting with Security. Q1 revenues were $264 million, up 4% year-over-year, despite a challenging geopolitical environment, including the conflict in the Middle East, which continues to affect activity in the region.
We continue to work closely with our customers there to support their ongoing needs. As anticipated, the transition of our MEXCO program affected year-over-year comparisons consistent with our initial fiscal '27 outlook. That said, Securities bookings were strong and the division ended the quarter with a record backlog. Let me share a few highlights from the quarter. During the quarter, we announced two five-year IDIQ contracts awarded by U.S. Customs and Border Protection, one with a ceiling of approximately $200 million for our relocatable rapid scan passenger vehicle inspection systems, and a second with a ceiling of about $85 million for van-mounted mobile x-ray inspection systems. We have received initial delivery orders totaling approximately $21 million under these contracts and expect more orders as we start delivering.
To be clear, only firm orders rather than ceiling values are included on the backlog figures. Our RF business is performing exceptionally well. We continue to execute on our Homeland Defense over the Horizon radar contract that was awarded last fiscal year, which has a not-to-exceed value of approximately $235 million and is our largest RF award to date. Together with our participation in the SHIELD IDIQ, which supports a number of Golden Dome-related initiatives, this award positions us well to compete for additional contracts in the future. In Q1, we announced further bookings in this business line, totaling approximately $90 million. Also, customer engagement across our RF portfolio remains at very high levels. Growing recurring revenues remains a priority.
We continue to expect strong double-digit service revenue growth in fiscal 2027, with growth accelerating throughout the year. Given the size of our install base, we expect service to become a larger part of our revenue mix over time, which should support margin expansion. While Security margins can vary from quarter to quarter with product and program mix, our long-term objective continues to focus on pairing growth with margin expansion as higher margin service revenue becomes a larger part of our business. We are also preparing for a role as an official physical screening and security technology hardware/software solutions provider of the LA28 Olympic and Paralympic Games and an official supporter of Team USA. This is expected to be the largest sporting event in history. Furthermore, our experience at the FIFA World Cup, the Paris Olympics, and Milan Winter Olympics, among many other global events, is vital to our success here. And we also see LA28 as a platform to showcase our offerings and compete for future large venue and event security opportunities.
Turning to our Optoelectronics and Manufacturing Division. Opto delivered another strong quarter. Revenues, including intercompany sales, were at a first quarter record of $120 million, up 9% year-over-year, with sales to third-party customers up even higher at 16% year-over-year. During the quarter, revenue growth was paired with operating margin expansion. Bookings were robust across our EMS, flex circuit, and Optoelectronics product lines, and the division closed the quarter with its highest quarter end backlog. Our long-standing OEM relationships, vertically integrated model, customized offerings, and global manufacturing footprint across North America, Europe, and Southeast Asia continue to serve customers well in aerospace, defense, healthcare, and industrial markets, particularly as they further diversify their supply chains. Finally, Healthcare faced a challenging quarter. Revenue declined 14% year-over-year, primarily due to lower patient monitoring sales as hospitals continued to manage capital spending carefully. We remain focused on supporting our install base, improving operational efficiency, and completing the development of our next-generation monitoring platform.
We expect Healthcare to return to growth in the upcoming quarters. In summary, our demand remains robust with a 1.4 book-to-bill ratio, a well-diversified $2.1 billion backlog, established CBP contract vehicles, promising additional U.S. government opportunities, a growing RF pipeline, and continued expansion in our Optoelectronics Division. Looking forward, we are focused on disciplined execution, converting our backlog into revenue, improving Healthcare, and driving margin expansion across our business. I want to thank our employees, customers, and stockholders for their continued support. With that, I will turn the call back over to Alan to discuss our financial results and updated fiscal 2027 guidance in more detail before we open the call for questions. Thank you.
Thank you, Ajay. So let's begin with our revenue performance. Product revenues grew 5% year-over-year to $290 million, and service revenues grew 4% to $114 million. By division, as Ajay mentioned, Opto grew 9%, including inter-segment sales, and 16% to external third-party customers. Security grew 4% and Healthcare declined 14%. We said on the last call that we expected the Mexico program transition would be a headwind of less than $25 million in fiscal '27, concentrated in the first half. In the first quarter, that headwind was approximately $8 million, consistent with that outlook.
And we anticipate in Q2, this amount to be approximately $11 million. And although service revenue growth was modest in Q1, but in line with our expectations, as Ajay said, we expect strong double-digit growth in fiscal '27 service revenues, led by the Security division, driven by a significant number of products rolling off warranty, aviation service, SAS, and increasing RF business, among other items. Our Q1 fiscal '27 gross margin was 30.7% compared to 32.0% in the first quarter of last year. The variance was primarily driven by the decline in Healthcare division sales, which carry the highest gross margin of our three divisions. In addition, the strength of Opto division sales, which carry the lowest gross margin of the three divisions, though operating margins are solid, impact us, and a less favorable mix of revenues this quarter within the Security division. As we noted in the past, our margins can fluctuate based on product and service mix, volume, supply chain costs, foreign exchange, tariffs, and other factors. We expect gross margin to increase over the balance of the year on higher overall revenues, including greater growth in higher margin service revenues. Moving on to operating expenses. We continue to work diligently across all divisions to manage our SG&A cost structure efficiently.
In Q1, SG&A was $69 million, or 17.0% of sales, compared with 17.4% of sales a year ago. R&D expenses in Q1 were $19.4 million, or 4.8% of revenue. We continue to invest substantial resources consistent with our commitment to innovation and positioning OSI well for the future. Total operating expenses, excluding restructuring and other costs, declined to 21.8% of sales in Q1 this year from 22.7% in the same quarter of the prior year. Now, moving below the operating line, interest and other expenses in fiscal Q1 were $3.3 million compared with $7.4 million in the same quarter of the prior year. This $4.1 million improvement was primarily due to reduced borrowing costs, coupled with increased investment income on higher cash and short-term investment balances. Our effective tax rate under GAAP was 18.8% in Q1 of fiscal '24, compared to 19.9% in Q1 last year. Excluding discrete items, the normalized effective tax rate, which is the rate we use in calculating non-GAAP EPS, was 22.9% in Q1 compared to 23.3% in the same prior year quarter.
On a non-GAAP basis, our Q1 fiscal '27 adjusted operating margin was 9.5% compared to 10.3% in the prior year first fiscal quarter. By division, non-GAAP operating margin was 12.6% in Security, 12.1% in Opto, and negative 1.8% in Healthcare. While we saw adjusted operating margin expansion in the Opto division, the operating loss in the Healthcare division and less favorable Security division mix drove the consolidated change. We anticipate stronger operating margins for the balance of fiscal '27 in each division and for OSI overall. Moving to cash flow in the balance sheet. We generated $37 million of operating cash flow in Q1 this year, compared to $17 million in last year's Q1. Accounts receivable at September 30th were $18 million lower than at June 30th, given Q1 revenues are historically lighter than in Q4.
While unbilled receivables rose $34 million, as we recognized revenue on certain Security contracts ahead of billing milestones. The receivable balance from our largest customer in Mexico slightly declined from June to September, as collections modestly outpaced revenue following significant Q4 collections. We continue to expect this receivable to decrease significantly by the end of fiscal '27, contributing to expected strong annual free cash flow conversion. Inventories increased $48 million during the quarter to $463 million to support strong second half scheduled deliveries from our backlog. CapEx in the first quarter was $7.7 million, while depreciation and amortization in the quarter was $9.0 million. During Q1, we repurchased approximately 306,000 shares at an average price of about $204 for approximately $62 million. Our board in August increased the authorization for stock repurchases by an additional 1 million shares.
And at the end of Q1, approximately 773,000 shares were available under the repurchase program. Our priorities remain organic investment, strategic acquisitions, opportunistic repurchases, and maintaining a strong balance sheet. Q1 diluted shares were 16.3 million, compared with 17.5 million a year ago, a 7% reduction, reflecting the repurchase and retirement of shares over the past year. Our balance sheet remains solid, providing us with significant flexibility. We ended the quarter with $236 million in cash and cash equivalents and $66 million in short-term investments, approximately $302 million in total, with total debt of approximately $1.0 billion and no amounts drawn under our bank lines of credit. With the capital returned to shareholders during Q1 through stock buybacks, net leverage under our credit agreement was approximately 2.3. Over 90% of our debt is at fixed rates, which limits our borrowing cost sensitivity to higher short-term interest rates.
Now, turning to our guidance. We are raising our fiscal 2027 non-GAAP EPS guidance, while reaffirming our fiscal '27 revenue guidance of $1.875 billion to $1.930 billion. We now expect non-GAAP EPS of $11.28 to $11.64, representing 9% to 12.5% year-over-year growth. The expected increase primarily reflects the favorable impact to EPS of stock repurchases made in Q1. As we said in August, we continue to expect revenue growth to be strongest in the second half of the fiscal year. We expect second quarter revenues to be modestly down year-over-year as Q2 represents the toughest Middle East comp with sizable revenues in the prior year period before the conflicts began along with the Mexico impact previously discussed. H2 revenue growth is underpinned by the timing of the expected conversion of our sizable backlog and a healthy funnel of new opportunities, coupled with the significant year-over-year growth expected in Security service revenues that we have previously discussed. We also continue to expect free cash flow to exceed net income for the full fiscal year.
Our guidance excludes potential impairment, restructuring, and other costs, amortization of acquired intangible assets and their associated tax effects, and discrete tax and other non-recurring items. Actual results could vary from guidance due to the timing of backlog conversion, new bookings, cash collections, tariffs, the conflicts in the Middle East, U.S. government funding and procurement timing, interest rates and supply chain disruptions, among other factors discussed in our SEC filings. In summary, we began fiscal '27 with record first quarter revenues, strong bookings, a record backlog, and cash generation running ahead of last year. We thank the entire global OSI team for their dedication. And at this time, we'd like to open the call to questions.
Thank you.
[Operator Instructions]
Our first question is going to come from the line of Josh Nichols with B. Riley Securities. Your line is open. Please go ahead.
Yes, thanks for taking my question and great to see the backlog well above $2 billion for the first time with a strong book-to-bill. You know, EPS obviously moving up higher. I know you're reiterating the top-line revenue guidance, but just with the backlog increase, I was just curious as part of that just being some conservatism given that there's already a second half weighting to the outlook? Or is this something that you think these new orders that you got are really just going to increase visibility for the company when you think about fiscal '28, '29 and the timing of those deliveries?
Josh, this is Alan. Great question, and we're really pleased with the record level of backlog that we have. Going into our guidance, we're still seeing conflicts going on in the Middle East and other geopolitical events. We just thought it prudent to maintain that revenue guidance at this time. Surely there is upside. And it sets us up quite nicely as we enter fiscal '28 and beyond as well.
Yep, and then just for a little bit more context, I'm guessing probably not, but was any of those Middle East orders that caused the one-time hiccup in last quarter, was any of that shifted or are you still expecting that to come in in the second half? And is there anything else big that you guys have been working on that you expect may come to fruition in terms of the order pipeline generally?
Yes, another good question, Josh. It's Alan. So, yes, we mentioned last time there was roughly $50 million pushed out of our fourth quarter. During our Q1, we shifted and recognized revenue about $8 million of that. I think that's the first quarter. Last time we said we expected the balance to mostly be in the second half of this year and even into fiscal '28. And that's still currently our expectation.
Yeah, you know, just this is Ajay, just to add on in terms of orders. Even with the Middle East situation, we had a great book-to-bill ratio. Orders are materializing at other places. And as I said, I think previously as well, as hopefully when the conflict ends, usually in the long run, it's an opportunity for us to get a lot more orders as people become more and more conscious of security around infrastructure and military facilities.
Yes, I appreciate that. That's a good point we're taking note of. I'll jump back into the queue and let someone else take a turn. Appreciate it. Thanks, guys. Good to see the progress here.
Thank you. And one moment for our next question. Our next question will come from the line of John Godyn with Citigroup. Your line is open. Please go ahead.
Hey, guys. Thanks for taking my question. I wanted to just talk a little bit about or hope you can elaborate a little bit on what's going on with services revenues. I think everybody is excited on the growth there, what it means for margins over time. It seems like there is a little bit of a blip, but you guys are confident that that mix is going to improve through the balance of the year and the Security division, any color you could provide would be great.
Sure, John. This is Alan. Good question. Yes. While our service revenue growth was modest at around 5% in Q1, we see a significant pickup year-over-year at each of Q2, Q3, and Q4. That's really underpinned by looking at the rollout of or products that we've installed coming off of warranty. That's a big part of it. Some of the aviation service revenue that we're doing, some of the SAS revenue such as SIRS-CAN, increasing revenue with our RF business and some various other items. So we actually have some very good visibility into the service revenue growth, which gives us a high degree of confidence for that strong double-digit growth in service revenue commencing really this quarter in Q2 and getting even stronger in the second half.
Got it. Great. That's very helpful. And if I could ask one more on the Middle East, you know, just reflecting what's out there in the news, you know, there is this concern of an escalation after the midterms. I just was hoping to think through that with you guys. If there was a dramatic escalation event, how might that impact your thinking? How might you guide investors to kind of think through the impact on the business?
So, I think, you know, as I said, in the long run, obviously, any, unfortunately, any conflict does benefit us with increased Security requirements. I think we've taken into account as much as possible what we think is going to happen, but obviously we don't have a crystal ball like anybody else. So we'll wait and see, but from what we know right now, we feel confident and we're looking what we think is going to happen over the next three quarters.
Excellent. Appreciate the color, guys.
Thank you and one moment for our next question. Our next question will come from the line of Christopher Glynn with Oppenheimer & Co. Your line is open. Please go ahead.
Hey, thanks. Good afternoon, guys. I want to ask a little bit about the RF business. You talked about growing RF pipeline and notwithstanding the large bookings you've had. You know, I know there's a lot of classified work you do there, but I'm curious if you could talk about the competitive landscape a little bit more about the differentiation that's winning, how unique is the offering and how dependent are the SERV programs on.
You guys singularly? So this is Ajay, you know, as we said previously, you know, it's the kind of business where it's pretty restricted what we can say or not say, but I will tell you that, you know, our offerings are regarded very favorably by customers. We have some very unique products that others do not have. And in certain areas, we definitely do dominate the market. So I think that without getting into specifics, we feel very good about our prospects going forward. And as I said in my prepared remarks, we are definitely very much talking to customers and discussing opportunities as we move forward.
Great. And just in terms of those large orders, the $235 million and the $90 million, curious how you know that's pacing to orders. I think it's a little more upfront than the CBP orders but just kind of curious.
Chris, this is Alan. Yes, so exciting for us. We are recognizing revenue on that $235 million contract as we speak. So we saw some nice revenues for that in Q1 and we'll continue to see it through the balance of this fiscal year. The new orders that we got for $90 million. We'll see some contribution this year and more contributions in out years as well.
It gives us great visibility in '27 and beyond.
Okay, great. Thanks very much. I'll move it along.
Thank you and one moment for our next question. Our next question will come from the line of Lawrence Solow with CJS Securities. Your line is open. Please go ahead.
Great, good afternoon. I guess a couple questions on the backlog, composition of the backlog. It sounds like most things are United States and U.S. focused, right? But they go there in August and then the $90 million on the golden dome on the RF side, I guess that's mostly U.S.. And is that, you know, no Middle East this year, you know, in your, in your guidance on sales and I'm sure in bookings, but is the carton, you know, majority or vast majority of bookings you expect this year domestic or is there some international, um, you know, stuff in the queue? Are close in the queue?
So, this is Ajay. I mean, bear in mind that we do business in 150 countries, so international business, we expect to continue. Obviously, Middle East is, you know, a blip right now, and hopefully that turns around. And we have, you know, domestic orders as well. So it really depends on a quarter by quarter, you know, whether it's domestic or international.
All right. And I guess the other question I have really is more importantly just in the U.S., is there any risk? You know, we're always looking over our shoulder on the Middle East and Iran. I'm just curious, the U.S., the reconciliation bill, reconciliation 3.0 I guess they call it. I guess after the midterms that that's supposed to be hopefully hashed out before year end, but is there a funding risk, particularly on Golden Dome, and maybe even, I don't think, I think that that's a separate funding for them, right? There's no actual funding in the, um in the traditional appropriations there. So I'm just curious, you know, is that something you guys are watching, you know, particularly on Golden Dome, but just, you know, obviously we had a government shutdown last year that impacted stuff for quite a while. So any thoughts on that would be great.
So, you know, a lot of this is out of our control, obviously, but keep in mind with the big, beautiful bill, a lot of the funding for, you know, for DHS, as well as the Golden Dome programs was already, you know, was already there. So that'll continue and we're still waiting for with CBP and others for that funding to be awarded. They've started the programs, but there's still a long ways to go. So I think that, you know, really from the original reconciliation bill, we're still waiting for orders to be released. I think that as far as the future is concerned, we feel even on the RF business that a lot of the funding is already there. Obviously, everybody looks for future funding, so we'll see what happens. But at this point, the programs we're in in the near term to short term, we feel pretty good.
Okay, great. Lastly, just for my take, just to summarize it, it sounds like obviously Q1 is a light Top line or mix was a top line was fine. Mix was a little bit light. I hurt your margins a little bit, but it doesn't sound like, you know, from an operating standpoint, much has really changed for your outlook this year. The increasing guidance is more because of your share buyback than anything else. Is that kind of fair to say?
Yes, Lawrence, this is Alan. That would be a fair statement at this point in time, yes.
All right. I'm all set then. Thanks. I appreciate it, guys.
Thank you. And one moment for our next question, which will come from the line of Seth Seifman with JP Morgan. Your line is open. Please go ahead.
Yes, thanks very much and good afternoon. Um, I wonder, you gave us some some helpful commentary about the the revenue in Q2, just so we're all kind of properly calibrated in terms of, you know, how we get to the year. Um, how do we think about the mix evolving? In Q2. I think, you know, you mentioned or recovery in services growth and, you know, the degree of sequential margin expansion that we might think about.
Yes, Seth, this is Alan. So you're correct. We tried to give some color for modeling purposes for Q2 that we give annual guidance. Revenue accelerating meaningfully in Q2, probably that type of growth, you know, doubling if not more than doubling in Q2 with continued acceleration in the second half of the year as well. So we would anticipate that will contribute nicely to expanding margins throughout the balance of the year.
Okay. And then maybe I guess as you think about capital deployment, we saw some good share purchase this quarter. Kind of the way that you think about that going forward, you know, still with good cash on the balance sheet and nice conversion this year. Are there interesting things to look at in M&A right now? Is that part of the outlook? Is it kind of more focused on executing this kind of growing backlog that you have and maybe we'll see some more share purchases? Maybe just some updated thoughts on capital deployment.
So, you know, we're, this is Ajay, we're always looking at organic growth. That's always our, you know, number one priority. And we think there are a lot of opportunities out there. So it's not that, you know, we absolutely need an acquisition, but we obviously look at acquisitions. We've done them in the past. And we need to look at acquisition that's strategic. That builds on our momentum and then really increases our market penetration or gives us some complementary markets that we're going after. And, you know, we're always looking at all those opportunities to think about share repurchases.
So there's no set rule here or there, but we look at all three opportunities and we still are.
Excellent. Thank you very much.
Thank you. And as a reminder, to ask a question, please press star 11 on your telephone. Our next question will come from the line of Jeffrey Martin with Ross Capital Partners. Your line is open. Please go ahead.
Thanks. Good afternoon, Ajay and Alan. Wanted to dig into, you know, how you're thinking about future investment in the RF business with the success that you're having. I know that you've built out overseas manufacturing, you know. Do we have significant capacity at this point, or are you going to have to look to expand capacity? And then could you also touch on, you know, either R&D or future investment and further in the our business?
So, you know, great question. And obviously, we want to make sure, and I'll address the R&D first, that, you know, we start and keep on investing in future products. You obviously want to invest when times are good. And we're actively looking at opportunities there. In terms of expansion. I think we mentioned before we moved into a new facility. We've actually moved into a second new facility. We feel that we have a very robust pipeline that we can meet with the current requirements that we have. And we can always go into a second shift and meet in.
And as we actively talk to customers, that's one of the things we're able to demonstrate that, yes, we have the ability to get more orders and grow and get them in a timely manner. And really, if necessary, it's the kind of business that if you have to add another facility, it will be fairly straightforward for us to do.
Great. I think that's the first time I've gotten a great question out of you, Ajay. Thank you. That's all I had. Thank you.
Thank you. And I'm showing no further questions at this time and I would like to hand the conference back over to Ajay for any closing remarks.
Once again, thank you all for joining our call. We look forward to speaking with you during our next earnings call following the completion of our fiscal 2027 second quarter. Hopefully all of you have an upcoming great holiday season. Thank you very much.
This concludes today's conference call. Thank you for participating, and you may now disconnect. Everyone, have a great day.
This live transcript is auto-generated without human intervention or review.